Strategy
Focus on leading positions in the pharmaceutical market
Diagnostic Imaging
Our innovative contrast media for imaging procedures make diagnoses more precise, safer and less stressful. In the field of molecular imaging we are pursuing promising approaches with novel carrier molecules in order to develop disease-specific substances for visualizing biological processes at the molecular level.
Hematology/Cardiology
More than half of all deaths worldwide are related to cardiovascular diseases. We have taken up the challenge of clarifying the complex biological processes involved and developing effective drugs.
Oncology
We are trying to achieve a breakthrough in tumor therapy with the aim of prolonging people's lives and improving their quality of life. We offer a broad range of therapies for lymphomas and the various forms of leukemia. In the case of solid tumors we are accelerating the launch of new drugs and pursuing promising strategies in active-ingredient development, such as anti-angiogenesis and cell-cycle control.
Primary Care
In future we want to continue improving our products that general practitioners prescribe to their patients. We are searching for new indications and formulations for these tried-and-tested products to make them even easier and safer to take. They include our well-known and proven anti-infectives, cardiovascular and metabolic drugs. Furthermore, in the field of men's healthcare we offer drugs for treating erectile dysfunction, as well as hormone preparations to combat testosterone deficiency in men. We are also working on methods of male fertility control.
Specialized Therapeutics
Serious chronic diseases like multiple sclerosis and Parkinson's disease put great strain on patients and their families. We want our drugs to give them new prospects. The primary aim of further developing established active ingredients is to improve the patients' quality of life.
